Practical guidance for the management of adults with immune thrombocytopenia during the COVID-19 pandemic

Br J Haematol. 2020 Jun;189(6):1038-1043. doi: 10.1111/bjh.16775. Epub 2020 Jun 2.

Abstract

This document aims to provide practical guidance for the assessment and management of patients with thrombocytopenia, with a particular focus on immune thrombocytopenia (ITP), during the COVID-19 pandemic. The intention is to support clinicians and, although recommendations have been provided, it is not a formal guideline. Nor is there sufficient evidence base to conclude that alternative approaches to treatment are incorrect. Instead, it is a consensus written by clinicians with an interest in ITP or coagulation disorders and reviewed by members of the UK ITP forum.

Keywords: ITP; TPO RA; intravenous immunoglobulin; platelets; steroids; thrombosis.

Publication types

  • Letter
  • Review

MeSH terms

  • Adult
  • Betacoronavirus*
  • COVID-19
  • Coronavirus Infections* / epidemiology
  • Coronavirus Infections* / etiology
  • Coronavirus Infections* / therapy
  • Female
  • Humans
  • Male
  • Pandemics*
  • Pneumonia, Viral* / epidemiology
  • Pneumonia, Viral* / etiology
  • Pneumonia, Viral* / therapy
  • Practice Guidelines as Topic
  • Purpura, Thrombocytopenic, Idiopathic* / congenital
  • Purpura, Thrombocytopenic, Idiopathic* / epidemiology
  • Purpura, Thrombocytopenic, Idiopathic* / therapy
  • SARS-CoV-2